Trial Profile
Memory functioning and antidepressant treatment: a randomized controlled trial comparing escitalopram and bupropion XL
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Bupropion (Primary) ; Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Pharmacodynamics; Therapeutic Use
- 16 Feb 2009 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 21 May 2007 Results have been reported.
- 08 Oct 2006 New trial record.